Zobrazeno 1 - 9
of 9
pro vyhledávání: '"T. O. Kurtz"'
Autor:
Leonard Harry Goldberg, R. H. Kaufman, R. L. Batenhorst, T. O. Kurtz, L. J. Eron, G. S. Boone, Marcus A. Conant
Publikováno v:
Journal of Medical Virology. 41:45-50
This study presents data relative to the efficacy and safety following the continuous use of oral acyclovir in the treatment of genital herpes over a 5-year period. In this study, 1,146 patients (53% males; 47% females) were originally enrolled. Thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bf9b808277d0dce4678f7023871783
https://doi.org/10.1002/jmv.1890410510
https://doi.org/10.1002/jmv.1890410510
Publikováno v:
Archives of dermatology. 129(5)
This multicenter trial (19 sites) was initiated in 1984 in more than 1100 immunocompetent individuals with a history of frequently recurring genital herpes (mean,or = 12 episodes per year). The first year of this suppressive therapy trial was placebo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58956861820234f3f15ad541a6fa3f42
https://pubmed.ncbi.nlm.nih.gov/8481018
https://pubmed.ncbi.nlm.nih.gov/8481018
Autor:
Gloria S. Boone, Leonard Harry Goldberg, L. J. Eron, Randal L. Batenhorst, Marcus A. Conant, T. O. Kurtz, Raymond H. Kaufman
Publikováno v:
Archives of Dermatology. 129:582
• Background and Design.— This multicenter trial (19 sites) was initiated in 1984 in more than 1100 immunocompetent individuals with a history of frequently recurring genital herpes (mean, ≥12 episodes per year). The first year of this suppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f98f8114675e6427f449da78c464f4a
https://doi.org/10.1001/archderm.1993.01680260052005
https://doi.org/10.1001/archderm.1993.01680260052005
Autor:
William L. Hewitt, William J. Martin, Drew J. Winston, T O Kurtz, Janet A. Hindler, Lowell S. Young
Publikováno v:
Antimicrobial Agents and Chemotherapy. 18:645-648
The in vitro activities of four new beta-lactam antimicrobial agents (moxalactam, cefotaxime, cefoperazone, and piperacillin) and the aminoglycosides against 744 recent clinical isolates of facultative gram-negative bacilli were compared simultaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf6b0b533e0bbaf4cf03f098711ecd5
https://doi.org/10.1128/aac.18.4.645
https://doi.org/10.1128/aac.18.4.645
Autor:
D A, Sisam, T O, Kurtz
Publikováno v:
The Journal of the American Osteopathic Association. 85(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9c57b2d20a5241554c93ddc1b1cb5c7
https://pubmed.ncbi.nlm.nih.gov/3884557
https://pubmed.ncbi.nlm.nih.gov/3884557
Publikováno v:
Archives of internal medicine. 141(12)
Moxalactam, a novel beta-lactam antimicrobial agent in which oxygen has replaced sulfur in the six-membered ring of the conventional cephem nucleus, has in vitro activity against almost all commonly isolated bacterial pathogens including Staphylococc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee5a5432dcabde0b7d0ec5e05cb5163a
https://pubmed.ncbi.nlm.nih.gov/6458253
https://pubmed.ncbi.nlm.nih.gov/6458253
Publikováno v:
Antimicrobial agents and chemotherapy. 20(2)
The in vitro synergistic activities of moxalactam, cefoperazone, or cefotaxime in combination with amikacin or piperacillin were compared against aminoglycoside-susceptible and aminoglycoside-resistant isolates of Pseudomonas aeruginosa and Serratia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0305e522138a8b39744f976587cda2
https://pubmed.ncbi.nlm.nih.gov/6792982
https://pubmed.ncbi.nlm.nih.gov/6792982
Autor:
G E, Stein, N, Mummaw, E J, Goldstein, E J, Boyko, L B, Reller, T O, Kurtz, K, Miller, C E, Cox
Publikováno v:
Archives of internal medicine. 147(10)
Two-hundred nine patients with symptoms of acute urinary tract infection and pyuria were randomized to 400 mg of administered norfloxacin twice daily for three days, or 800 mg of sulfamethoxazole and 160 mg of trimethoprim administered twice daily fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7462f2efa51ab2987bb3dac84df3fcce
https://pubmed.ncbi.nlm.nih.gov/3310941
https://pubmed.ncbi.nlm.nih.gov/3310941
Publikováno v:
The Journal of the American Osteopathic Association. 88(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c826242fdc2b83af91d1758bbf7381a1
https://pubmed.ncbi.nlm.nih.gov/3266869
https://pubmed.ncbi.nlm.nih.gov/3266869